Premium
Evommune Inc (EVMN)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Dr. David Eric CohenIndependent Director | -6,06k | 123,09k | Automatic Disposition | 20,21 - 21,38 | 17,61k | -25,59% |
| 2026-06-01 | Dr. Jeegar PatelChief Scientific Officer | -13,51k | 255,38k | Derivative Exercise and Sale | 3,84 - 22,74 | 5,97k | - |
| 2026-06-01 | Dr. Jeegar PatelChief Scientific Officer | -3,18k | 72,20k | Automatic Disposition | 22,74 | 5,97k | -34,73% |
| 2026-06-01 | Mr. Luis C. PenaFounder, President, CEO & Director | -16,79k | 381,74k | Automatic Disposition | 22,74 | 496,14k | -3,27% |
| 2026-05-28 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | -14,22k | 300,39k | Derivative Exercise and Sale | 1,71 - 22,83 | 8,17k | - |
| 2026-05-28 | Mr. Kyle CarverCFO | -15,00k | 297,75k | Derivative Exercise and Sale | 2,99 - 22,84 | 4,87k | - |
| 2026-05-28 | Mr. Kyle CarverCFO | -3,18k | 72,52k | Automatic Disposition | 22,84 | 4,87k | -39,49% |
| 2025-12-19 | Dr. Robert L. HopfnerIndependent Director | 1 000,00 | 17,35k | Achat | 17,35 | 4,03k | 33,05% |
| 2025-12-09 | Dr. Jeegar PatelChief Scientific Officer | -7,51k | 134,03k | Sale to Issuer | 17,84 | 9,14k | -45,11% |
| 2025-12-09 | Mr. Luis C. PenaFounder, President, CEO & Director | -28,14k | 501,98k | Sale to Issuer | 17,84 | 512,93k | -5,20% |
| 2025-12-09 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | -13,62k | 243,05k | Sale to Issuer | 17,84 | 8,17k | -62,52% |
| 2025-12-09 | Mr. Kyle CarverCFO | -13,29k | 237,09k | Sale to Issuer | 17,84 | 8,04k | -62,30% |
| 2025-12-09 | Ms. Janice DrewChief of Development Operations | -5,07k | 90,52k | Sale to Issuer | 17,84 | 40,75k | -11,07% |
| 2025-12-09 | Dr. Eugene Andrew BauerCo-Founder, Chief Medical Officer & Director | -1,48k | 26,37k | Sale to Issuer | 17,84 | 262,05k | -0,56% |
| 2025-11-07 | RA Capital Management, L.P.Société | 2,21M | 0,00 | Derivative Exercise and Retained Stock | - | 3,46M | 176,70% |
| 2025-11-07 | RA Capital Management, L.P.Société | 1,25M | 20,00M | Achat | 16,00 | 3,46M | 56,59% |
| 2025-11-07 | Eqt Fund Management S.à R.L.Société | 3,37M | 0,00 | Derivative Exercise and Retained Stock | - | 4,93M | 215,50% |
| 2025-11-07 | Eqt Fund Management S.à R.L.Société | 1,56M | 25,00M | Achat | 16,00 | 4,93M | 46,40% |
| 2025-11-07 | Mr. Luis C. PenaFounder, President, CEO & Director | 24,23k | 0,00 | Derivative Exercise and Retained Stock | - | 493,82k | 5,16% |
| 2025-11-07 | Dr. Jeegar PatelChief Scientific Officer | 3,18k | 0,00 | Derivative Exercise and Retained Stock | - | 3,18k | - |
| 2025-11-07 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | 3,18k | 0,00 | Derivative Exercise and Retained Stock | - | 3,18k | - |
| 2025-11-07 | Dr. Robert L. HopfnerIndependent Director | 3,03k | 0,00 | Derivative Exercise and Retained Stock | - | 3,03k | - |
| 2025-11-07 | Pivotal BioVenture Partners LLCSociété | 1,93M | 0,00 | Derivative Exercise and Retained Stock | - | 1,93M | - |
| 2025-11-07 | NFLS Delta III LimitedSociété | 1,44M | 0,00 | Derivative Exercise and Retained Stock | - | 1,44M | - |
| 2025-11-07 | Ms. Janice DrewChief of Development Operations | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 36,81k | 4,51% |
| 2025-11-07 | Dr. David Eric CohenIndependent Director | 6,06k | 0,00 | Derivative Exercise and Retained Stock | - | 23,67k | 34,39% |
| 2025-11-07 | Mr. Kyle CarverCFO | 3,18k | 0,00 | Derivative Exercise and Retained Stock | - | 3,18k | - |
| 2025-11-07 | Dr. Eugene Andrew BauerCo-Founder, Chief Medical Officer & Director | 25,81k | 0,00 | Derivative Exercise and Retained Stock | - | 260,61k | 10,99% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
